JENNISON ASSOCIATES
Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969. Today, the firm manages over $93 billion for institutions and private clients through separately managed accounts and commingled vehicles, including mutual funds through subadvisory relationships.
JENNISON ASSOCIATES
Industry:
Financial Services Venture Capital
Founded:
1969-01-01
Status:
Active
Contact:
+1 212 421 1000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Font Awesome Mobile Non Scaleable Content Euro Microsoft Exchange Online Amazon
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-06-28 | Electric Last Mile Solutions | Jennison Associates investment in Post-IPO Equity - Electric Last Mile Solutions | 155 M USD |
2021-06-23 | Talkspace | Jennison Associates investment in Post-IPO Equity - Talkspace | 300 M USD |
2021-03-17 | Reunion Neuroscience | Jennison Associates investment in Post-IPO Equity - Reunion Neuroscience | 95 M CAD |
2021-01-08 | Clover Health | Jennison Associates investment in Post-IPO Equity - Clover Health | 400 M USD |
2018-09-07 | Allogene Therapeutics | Jennison Associates investment in Convertible Note - Allogene Therapeutics | 120 M USD |
2015-08-24 | Syndax Pharmaceuticals | Jennison Associates investment in Series C - Syndax Pharmaceuticals | 80 M USD |
2015-08-18 | Wave Life Sciences | Jennison Associates investment in Series B - Wave Life Sciences | 66 M USD |
2015-08-11 | Ovid Therapeutics | Jennison Associates investment in Series B - Ovid Therapeutics | 75 M USD |
2015-08-10 | Editas Medicine | Jennison Associates investment in Series B - Editas Medicine | 120 M USD |
2015-07-23 | GenSight Biologics | Jennison Associates investment in Series B - GenSight Biologics | 36 M USD |